Clearside Biomedical, Inc. Contracts & Agreements

Employment Agreement, by and between Registrant and Victor Chong, dated as of June 19, 2024 (Filed With SEC on August 12, 2024)

First Amendment to License Agreement, by and among the Registrant and BioCryst Pharmaceuticals, Inc., dated as of May 20, 2024 (Filed With SEC on August 12, 2024)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 10, 2024)

License Agreement, by and between the Registrant and BioCryst Pharmaceuticals, Inc., dated as of November 1, 2023 (Filed With SEC on March 12, 2024)

Fourth Amendment to License Agreement, by and among the Registrant, Emory University and The Georgia Tech Research Corporation, dated January 31, 2024 (Filed With SEC on March 12, 2024)

First Amendment to Consulting Agreement, by and between Registrant and Thomas Ciulla, dated as of February 17, 2024 (Filed With SEC on March 12, 2024)

Form of Warrant (Filed With SEC on February 8, 2024)

Form of Securities Purchase Agreement, dated February 6, 2024 by and among Clearside Biomedical, Inc. and the purchasers party thereto (Filed With SEC on February 8, 2024)

Placement Agency Agreement, dated February 6, 2024 by and among Clearside Biomedical, Inc. and Citizens JMP Securities, LLC (Filed With SEC on February 8, 2024)

Letter Agreement, dated December 22, 2023, by and among Clearside Royalty LLC, Healthcare Royalty Partners IV, L.P. and HCR Clearside SPV, LLC (as assignee of HCR Collateral... (Filed With SEC on December 28, 2023)

Controlled Equity OfferingSM Sales Agreement, dated as of May 12, 2023, by and between the Company and Cantor Fitzgerald & Co (Filed With SEC on May 12, 2023)

Purchase and Sale Agreement, by and among Clearside Royalty LLC, Healthcare Royalty Partners IV, L.P. and HCR Collateral Management, LLC (in its capacity as agent for Purchaser),... (Filed With SEC on November 9, 2022)

Fourth Amended and Restated Non-employee Director Compensation Policy (Filed With SEC on August 12, 2022)

Third Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 11, 2022)

First Amendment to the License Agreement by and between the Registrant and Arctic Vision (Hong Kong) Limited, dated as of August 15, 2021 (Filed With SEC on November 10, 2021)

Second Amendment to the License Agreement by and between the Registrant and Arctic Vision (Hong Kong) Limited, dated as of September 9, 2021 (Filed With SEC on November 10, 2021)

Second Amendment to the License Agreement by and between the Registrant and Bausch + Lomb Ireland Limited (as assignee of Bausch Health Ireland Limited), dated as of September 27,... (Filed With SEC on November 10, 2021)

First Amendment to License Agreement, by and between the Registrant and Bausch Health Ireland Limited, dated as of April 27, 2020 (Filed With SEC on August 10, 2020)

Executive Employment Agreement, by and between Clearside Biomedical, Inc. and Thomas Ciulla, dated as of June 24, 2019 (Filed With SEC on August 10, 2020)

Consent and Fifth Amendment to Second Amended and Restated Loan and Security Agreement, by and between the Registrant and Silicon Valley Bank, dated as of March 11, 2020 (Filed With SEC on May 8, 2020)

License Agreement, by and between the Registrant and Arctic Vision (Hong Kong) Limited, dated as of March 10, 2020 (Filed With SEC on May 8, 2020)

Amended and Restated Executive Employment Agreement, dated March 11, 2020, by and between the Company and George Lasezkay (Filed With SEC on March 16, 2020)

Separation Agreement, by and between the Registrant and Daniel White, dated as of April 7, 2019 (Filed With SEC on March 13, 2020)

Description of Common Stock of Clearside Biomedical, Inc (Filed With SEC on March 13, 2020)

Third Amendment to Second Amended and Restated Loan and Security Agreement, by and between the Registrant and Silicon Valley Bank, dated as of October 18, 2019 (Filed With SEC on March 13, 2020)

Consent and Fourth Amendment to Second Amended and Restated Loan and Security Agreement, by and between the Registrant and Silicon Valley Bank, dated as of October 22, 2019 (Filed With SEC on March 13, 2020)

Consulting and Independent Contractor Agreement, by and between the Registrant and Brion Raymond, dated as of January 3, 2020 (Filed With SEC on March 13, 2020)

Separation Agreement, by and between the Registrant and Brion Raymond, dated as of January 3, 2020 (Filed With SEC on March 13, 2020)

Option and License Agreement by and between the Registrant and REGENXBIO Inc., dated as of August 29, 2019 (Filed With SEC on March 13, 2020)

License Agreement, by and between the Registrant and Bausch Health Ireland Limited, dated as of October 22, 2019 (Filed With SEC on March 13, 2020)

Registration Rights Agreement, dated November 22, 2019, by and among the Company and the other parties thereto (Filed With SEC on November 25, 2019)

Securities Purchase Agreement, dated November 22, 2019, by and among the Company and the other parties thereto (Filed With SEC on November 25, 2019)

Consent and Second Amendment to Second Amended and Restated Loan and Security Agreement, by and between the Registrant and Silicon Valley Bank, dated as of August 29, 2019 (Filed With SEC on November 8, 2019)

Amendment to offer letter agreement, by and between the Registrant and George Lasezkay, dated as of August 6, 2019 (Filed With SEC on August 8, 2019)

Consent and First Amendment to Second Amended and Restated Loan and Security Agreement, by and between the Registrant and Silicon Valley Bank, dated as of July 3, 2019 (Filed With SEC on August 8, 2019)

Third Amendment to License Agreement, by and among the Registrant, Emory University and Georgia Tech Research Corporation, dated April 1, 2018 (Filed With SEC on August 8, 2019)

Letter Agreement, dated April 16, 2019, by and between the Company and George Lasezkay (Filed With SEC on April 17, 2019)

Executive Employment Agreement, by and between the Company and Brion S. Raymond, dated as of February 20, 2018 (Filed With SEC on March 15, 2019)

Supply Agreement, by and between Registrant and Gerresheimer Regensburg GMBH, dated as of May 8, 2018 (Filed With SEC on August 8, 2018)

Change in Control Equity Acceleration Plan, amending the Registrants 2016 Equity Incentive Plan (Filed With SEC on August 8, 2018)

Second Amended and Restated Loan and Security Agreement, dated as of May 14, 2018, by and among the Registrant, Silicon Valley Bank, MidCap Funding III Trust and MidCap Financial... (Filed With SEC on May 15, 2018)

Underwriting Agreement by and among Clearside Biomedical, Inc., J.P. Morgan Securities LLC and Cowen and Company, LLC, dated March 7, 2018 (Filed With SEC on March 8, 2018)

Amended and Restated Executive Employment Agreement, by and between Clearside Biomedical, Inc. and Daniel H. White, dated as of August 3, 2017 (Filed With SEC on November 9, 2017)

Amended and Restated Executive Employment Agreement, by and between Clearside Biomedical, Inc. and Charles A. Deignan, dated as of August 3, 2017 (Filed With SEC on November 9, 2017)

Amended and Restated Executive Employment Agreement, by and between Clearside Biomedical, Inc. and Glenn Noronha, dated as of August 3, 2017 (Filed With SEC on November 9, 2017)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 9, 2017)

First Amendment to Amended and Restated Loan and Security Agreement, by and among the Company, Silicon Valley Bank, ELM 2016-1 Trust and Midcap Financial Trust, dated as of... (Filed With SEC on November 2, 2017)

CLEARSIDE BIOMEDICAL, INC. $50,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on July 3, 2017)

SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on March 16, 2017)

[] Shares Clearside Biomedical, Inc. Common Stock ($0.001Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on December 7, 2016)

900 NORTH POINT PARKWAY ALPHARETTA, GEORGIA 30005 OFFICE LEASE AGREEMENT BETWEEN BRE/COH GA LLC, aDelaware limited liability company (LANDLORD) AND CLEARSIDE BIOMEDICAL,INC., a... (Filed With SEC on November 23, 2016)

AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on October 4, 2016)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on October 4, 2016)

AMENDMENT NO. 3 TO COLLABORATION AGREEMENT (Filed With SEC on May 11, 2016)

Shares Clearside Biomedical, Inc. Common Stock ($0.001Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on May 11, 2016)

CLEARSIDE BIOMEDICAL, INC. 2016 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 21, 2016 APPROVED BY THE STOCKHOLDERS:[ ], 2016 IPO DATE/EFFECTIVEDATE: [ ], 2016 (Filed With SEC on March 18, 2016)

CLEARSIDE BIOMEDICAL, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2016 EQUITY INCENTIVE PLAN) (Filed With SEC on March 18, 2016)

CLEARSIDE BIOMEDICAL, INC. STOCK OPTION GRANT NOTICE (2016 EQUITY INCENTIVE PLAN) (Filed With SEC on March 18, 2016)

CLEARSIDE BIOMEDICAL, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 21, 2016 APPROVED BY THE STOCKHOLDERS:[ ], 2016 (Filed With SEC on March 18, 2016)

CLEARSIDE BIOMEDICAL, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 18, 2016)

CLEARSIDE BIOMEDICAL, INC. 2011 STOCK INCENTIVE PLAN (Filed With SEC on January 8, 2016)

CLEARSIDE BIOMEDICAL, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT November 23, 2015 CLEARSIDE BIOMEDICAL, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on January 8, 2016)

CLEARSIDE BIOMEDICAL, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on January 8, 2016)

STOCK WARRANT (Filed With SEC on January 8, 2016)

WARRANT TO PURCHASE STOCK (Filed With SEC on January 8, 2016)

LICENSE AGREEMENT between EMORYUNIVERSITY, THE GEORGIA TECH RESEARCH CORPORATION and CLEARSIDEBIOMEDICAL, INC. TABLE OF CONTENTS (Filed With SEC on January 8, 2016)

LEASE AGREEMENT (Filed With SEC on January 8, 2016)

LICENSE AGREEMENT by and between CLEARSIDE BIOMEDICAL, INC. and NOVAMEDICA LLC Confidential andProprietary CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT.... (Filed With SEC on January 8, 2016)

CLEARSIDE BIOMEDICAL, INC. NOTICE OF INCENTIVE STOCK OPTION 2011 STOCK INCENTIVE PLAN (Filed With SEC on January 8, 2016)

CLEARSIDE BIOMEDICAL, INC. NOTICE OF NONSTATUTORY STOCK OPTION 2011 STOCK INCENTIVE PLAN (Filed With SEC on January 8, 2016)

AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (Filed With SEC on January 8, 2016)

COLLABORATION AGREEMENT (Filed With SEC on January 8, 2016)

AMENDMENT NO. 2 TO COLLABORATION AGREEMENT (Filed With SEC on January 8, 2016)

AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 8, 2016)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 8, 2016)

LOAN AND SECURITY AGREEMENT (Filed With SEC on January 8, 2016)

RESEARCH, OPTION AND LICENSE AGREEMENT (Filed With SEC on January 8, 2016)

Category

Industry

Companies

Contracts

Clearside Biomedical, Inc. Contracts & Agreements